Gastroenterology

Circle of Experts: Strategies for
Improving Outcomes of Patients
with Chronic HBV

This CME activity has reached its termination date and no longer offers continuing education credit. Please note that expired CME activities may not contain the most up-to-date information available.

Click here to view our current activities in Gastroenterology.

You may also be interested in Advanced Certificate Program III: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities

Circle of Experts:
Strategies for Improving Outcomes of Patients with Chronic HBV
Free 1.5-hour CME/CE Webcast Featuring Expert Faculty

View Webcast - requires Flash & high-speed Internet (Tech. Requirements)
View/Download Slides
View/Download Syllabus
Order the CD-ROM version of this webcast.

Dear Colleague,

The Circle of Experts: Strategies for Improving Outcomes of Patients with Chronic HBV webcast has been developed to help clinicians stay up-to-date on the complex diagnostic, treatment, and monitoring strategies related to the therapeutic agents currently available to treat chronic hepatitis B virus (HBV) infection.

This webcast reviews the epidemiology and natural history of HBV infection; examines the diagnostic challenges involved in using histologic, serologic, virologic, and biochemical measurements; discusses how these findings interact with the choice of current and emerging treatments; and offers guidance on managing the care of difficult-to-treat patients.

We encourage you to order your free CD-ROM or view the webcast online today!

Sincerely,

CHAIR
Adrian M. Di Bisceglie, MD, FACP Professor of Internal Medicine Chief of Hepatology Saint Louis University School of Medicine St. Louis, Missouri

FACULTY
Gary L. Davis, MD Director of Hepatology Baylor University Medical Center Dallas, Texas	Marion Peters, MD Professor of Medicine Chief of Hepatology Research University of California, San Francisco San Francisco, California
Robert P. Perrillo, MD Director, Academic Affairs Ochsner Clinic Foundation New Orleans, Louisiana	Mario Rizzetto, MD Professor of Gastroenterology Department of Gastroenterology University of Torino Medical Center Torino, Italy

top

TARGET AUDIENCE

This satellite symposium is designed for gastroenterologists and hepatologists who care for patients with hepatitis B infection and patients who are at increased risk for acquiring the infection.

ACTIVITY GOAL

The goal of this activity is to provide gastroenterologists and hepatologists who see patients with hepatitis B infection and patients who are at increased risk for acquiring the infection with state-of-the-art information on the pathophysiology of chronic HBV as well as current and emerging therapies. The program provides lectures as well as clinical case studies for discussion in a theater-style setting by experts in the field.

LEARNING OBJECTIVES

Given the epidemiology and natural history of chronic HBV infection, determine the differences between HBeAg-positive and HBeAg-negative chronic HBV to determine potential patient morbidity and mortality.
Integrate an understanding of factors contributing to the progress of chronic HBV into actionable steps to improve patient morbidity and mortality.
Evaluate current diagnostic and monitoring approaches in chronic HBV patients to determine the stage of disease.
Based on the efficacy and safety of current and emerging therapies, differentiate therapies and formulate strategies for the treatment of chronic HBV to improve response rates in a broad spectrum of patients.
Incorporate current and emerging therapies into treatment approaches for the "difficult-to-treat" chronic HBV patient with the goal of improving patients' responses.

top

CME INFORMATION

Statement of Accreditation

Projects In Knowledge is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Projects In Knowledge designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity is planned and implemented as an independent CME activity in accordance with the ACCME Essential Areas and Policies.

Contract for Mutual Responsibility in CME/CE
Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.
For more information on the contract, click here.

top

DISCLOSURE INFORMATION

The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials.

For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Adrian M. Di Bisceglie, MD, FACP has received grant/research support from Gilead Sciences, Inc, Idenix Pharma-ceuticals Inc, Roche Pharmaceuticals, SciClone Pharmaceuticals, Schering-Plough Corporation and Vertex Pharmaceuticals Incorporated; is a consultant for Abbott Laboratories, Bristol-Myers Squibb Company, Chiron Corporation, and SciClone Pharmaceuticals; is on the speakers bureau of Bristol-Meyers Squibb Company, Gilead Sciences, Inc, Roche Pharma-ceuticals, and Schering-Plough Corporation; is a member of advisory boards for Bristol-Meyers Squibb Company, Idenix Pharmaceuticals, Inc, Novartis Pharmaceuticals Corporation, Roche Pharmaceuticals, and Vertex Pharmaceuticals Incorporated; and is a member of Data Safety Monitoring Board for Schering-Plough Corporation.

Gary L. Davis, MD, has received grant/research support from Idenix Pharmaceuticals, Inc, Roche Pharmaceuticals, Schering-Plough Corporation, SciClone Pharmaceuticals, and Vertex Pharmaceuticals Incorporated.

Robert P. Perrillo, MD, has received grant/research support from Roche Pharmaceuticals, Schering-Plough Corporation, and Vertex Pharmaceuticals Incorporated; is a consultant for Gilead Sciences Inc, GlaxoSmithKline, and Roche Pharmaceuticals; is on the speakers bureau of GlaxoSmithKline; is a member of advisory boards for Gilead Sciences Inc, GlaxoSmithKline, and Roche Pharmaceuticals; and has received honoraria from Gilead Sciences Inc, Roche Pharmaceuticals, and Schering-Plough Corporation.

Marion Peters, MD, has received grant/research support from Gilead Sciences, Inc, and Roche Pharmaceuticals; is a consultant for Bristol-Myers Squibb Company and Roche Pharmaceuticals; is on the speakers bureau of Axcan Pharma, Bristol-Myers Squibb Company, Gilead Sciences, Inc, Roche Pharmaceuticals, and Schering Corporation; and is on the advisory board of Roche Pharmaceuticals. Dr. Peters has disclosed that she will reference unlabeled/unapproved use of tenofovir for HBV.

Mario Rizzetto, MD, is a member of advisory boards for Gilead Sciences Inc, Roche Pharmaceuticals, and Schering-Plough Corporation.

Peer Reviewer has disclosed no significant relationships.

Projects In Knowledge's staff members have no significant relationships to disclose.

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

This independent CME activity is supported by an educational grant from
Bristol-Myers Squibb Company.

top

1739

Circle of Experts: Strategies for Improving Outcomes of Patients with Chronic HBV Free 1.5-hour CME/CE Webcast Featuring Expert Faculty

Circle of Experts:
Strategies for Improving Outcomes of Patients with Chronic HBV
Free 1.5-hour CME/CE Webcast Featuring Expert Faculty